Study of the Determinants of Emergency Dialysis in Reunion Island

Among patients followed by nephrologists, the frequency of emergency dialysis starts' and their social and clinical determinants are not well known, especially in Reunion Island. In this context, we aim to study and understand the determinants of emergency dialysis initiation. For Reunion Island, the data remain very fragmented.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dialysis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de la Réunion

Saint-Denis, 97400, Reunion

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patient ≥18 years
Starting dialysis in a dialysis centre in Réunion Island
Having expressed their non-opposition or Emergency inclusion (non-opposition collected afterwards)

Exclusion criteria

Under legal protection (safeguard of justice, guardianship)
Unable to answer questionnaires

Treatment and study plan

Primary outcomes

Characteristics of emergency analysis

Time frame: 24 hours

Incidence rate of emergency dialysis

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de la Réunion

Other

Registry information

Official study title

Prevalence and Epidemiology of Extra Renal Replacement Therapy

Acronym: PEPER

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Mar 31, 2022
Registry last updated: Mar 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed